Clinical Research Directory
Browse clinical research sites, groups, and studies.
Exoskeleton Gait Training in Guillain-Barré Syndrome: Safety, Feasibility, Usability, and Longitudinal Outcomes
Sponsor: Institut Guttmann
Summary
The main objective of the study is to determine if the Atalante X exoskeleton by Wandercraft is a safe, reliable, and usable device for people with Guillain-Barré Syndrome (GBS) who are unable to walk. The secondary objective is to assess the impact of using this device on the gait and functional recovery of this type of users (GBS). The users undergo 20 training sessions over 6 weeks. Assessments are carried out at baseline, post-intervention, and at a 4-week follow-up after completing the training sessions. In all assessments, the same outcomes is conducted using the Medical Research Council Outcome, 10-Meter Walk Test, 6-Minute Walking Test, Kansas University Standing Balance Scale, Functional Independence Measure and Level of Assistence. To assess satisfaction, the QUEST 2.0 scale is administered. During this 20 sessions, monitoring is conducted for possible adverse effects that may appear and for the time required for donning and doffing the device.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
11
Start Date
2023-08-07
Completion Date
2025-12-12
Last Updated
2026-05-08
Healthy Volunteers
No
Conditions
Interventions
Exoskeleton Wandercraft Atalante X, usability and gait rehabilitation
Exoskeleton Wandercraft Atalante X trainning in Guillain Barre syndrome
Locations (1)
Institut Guttmann
Badalona, Barcelona, Spain